SXTC
China SXT Pharmaceuticals, Inc. Ordinary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
SXTC Stock Analysis: Buy, Sell, or Hold?
$2.83
-0.05 (-1.74%)
âŧ
5d:
-5.03%
30d:
+3556.33%
90d:
-14.24%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (35%)
Quality Score
31/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$0.25 â $3.19
Position: SLIGHTLY HIGH
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.71 / $3.70
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: SXTC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When SXTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SXTC is currently trading at $2.83, which is considered slightly high relative to its 30-day fair value range of $0.25 to $3.19.
Technical Outlook: Technically, SXTC is showing sideways momentum. Immediate support is located at $2.71, while resistance sits at $3.70.
Market Sentiment: SXTC scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SXTC is showing sideways momentum. Immediate support is located at $2.71, while resistance sits at $3.70.
Market Sentiment: SXTC scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.25 -
$3.19
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
35.3%
Trading Range & Key Levels
30-Day Trading Range
$0.25 -
$3.19
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$2.71
Resistance Level
$3.70
Current Trend
Sideways
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- WARNING: Composite score 31/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Revenue Growth (YoY)
-43.9%
Earnings Growth (YoY)
42.6%
Share SXTC Analysis
Share this live SXTC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SXTC)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment is dominating $SXTC on StockTwits with one trader expressing disappointment in the company's handling and considering short positions.
Key Retail Themes:
bearish sentiment
short positions
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:50 PM ET
Data refreshes hourly during market hours. Next update: 9:50 PM
Data refreshes hourly during market hours. Next update: 9:50 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SXTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences IâĻ |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 33 SELL |
|
AQST
Aquestive Therapeutics IâĻ |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
UTHR
United Therapeutics CorpâĻ |
STRONG BUY
15 analysts |
$687 | 52 HOLD |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 53 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SXTC Research Pages
